The EP PerMed Fast Track Call provides an accelerated pathway for personalised medicine innovators to validate their solutions. The recordings of the webinar for interested applicants on 21 January 2025 are now available.

Rationale of the Call
The EP PerMed Fast Track Validation Programme has been established to address a critical bottleneck in the development of PM solutions: the validation phase. Personalised medicine is a highly innovative and technology-driven field that holds immense potential for improving patient outcomes and optimising healthcare delivery. However, transforming groundbreaking innovations into market-ready products requires rigorous validation to ensure they meet the needs and expectations of end-users, including clinicians and patients.
Validation is essential for achieving and maintaining product-market fit, a key determinant of commercial success. It involves a thorough assessment of whether a product or feature effectively addresses the identified needs and bottlenecks. This process is often conducted in specialised validation centres, which provide the necessary infrastructure and expertise to test and validate innovations. Despite the availability of numerous validation centres across Europe, many innovators struggle to identify and access these resources, hindering the progress of their projects.
Programme overview
The Fast Track Validation Programme seeks to give support to overcome these challenges by providing a structured, accelerated pathway for PM innovators to validate their solutions. By leveraging a network of validation centres, the programme offers participants the opportunity to obtain critical evidence and feedback within a condensed timeframe of six months. This expedited process helps innovators swiftly advance their projects by at least one technology readiness level (TRL) and also enhances their readiness for market entry and commercialisation.
The programme supports start-ups and small teams and researchers at a pivotal stage of development, ensuring that promising PM innovations do not stall due to lack of validation resources and guidance. Through a combination of access to top-tier validation facilities, the Fast Track Validation Programme equips innovators with the tools and knowledge necessary to bring their solutions closer to clinical use and patient benefit.
Recordings & Slides
